Viwit Pharmaceuticals Limited
FDA Approved Drugs
Viwit Pharmaceuticals Limited
FDA Approved Drugs Database
FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.
- Total Records 14
- Latest Approval Date Aug 10, 2026
- Data Source FDA
- First Approval Date Sep 28, 2021
Company Overview
Social Profiles
Company Snapshot
Viwit Pharmaceuticals Limited
88 Weizhi Road, Tengzhou Biopharma Park, Shandong - 277514
China
www.viwit.com/ service@viwit.com View on MapFDA Approved Drug Records ( 14 records )
Drug Name
GADOBUTROL
Product Number
1
Dosage Form
-
Strength
4.5354GM/7.5ML (604.72MG/ML)
Approval Date
2026-06-11
Active Ingredient
GADOBUTROL
Application Number
219287
Product Number
1
Dosage Form
-
Strength
4.5354GM/7.5ML (604.72MG/ML)
Approval Date
2026-06-11
Regulatory Status
RX
Drug Name
GADOBUTROL
Product Number
2
Dosage Form
-
Strength
6.0472GM/10ML (604.72MG/ML)
Approval Date
2026-06-11
Active Ingredient
GADOBUTROL
Application Number
219287
Product Number
2
Dosage Form
-
Strength
6.0472GM/10ML (604.72MG/ML)
Approval Date
2026-06-11
Regulatory Status
RX
Drug Name
GADOBUTROL
Product Number
3
Dosage Form
-
Strength
9.0708GM/15ML (604.72MG/ML)
Approval Date
2026-06-11
Active Ingredient
GADOBUTROL
Application Number
219287
Product Number
3
Dosage Form
-
Strength
9.0708GM/15ML (604.72MG/ML)
Approval Date
2026-06-11
Regulatory Status
RX
Drug Name
GADOTERATE MEGLUMINE
Product Number
1
Dosage Form
-
Strength
3.769GM/10ML (376.9MG/ML)
Approval Date
2026-08-10
Active Ingredient
GADOTERATE MEGLUMINE
Application Number
219286
Product Number
1
Dosage Form
-
Strength
3.769GM/10ML (376.9MG/ML)
Approval Date
2026-08-10
Regulatory Status
RX
Drug Name
GADOTERATE MEGLUMINE
Product Number
2
Dosage Form
-
Strength
5.6535GM/15ML (376.9MG/ML)
Approval Date
2026-08-10
Active Ingredient
GADOTERATE MEGLUMINE
Application Number
219286
Product Number
2
Dosage Form
-
Strength
5.6535GM/15ML (376.9MG/ML)
Approval Date
2026-08-10
Regulatory Status
RX
Drug Name
GADOTERATE MEGLUMINE
Product Number
3
Dosage Form
-
Strength
7.538GM/20ML (376.9MG/ML)
Approval Date
2026-08-10
Active Ingredient
GADOTERATE MEGLUMINE
Application Number
219286
Product Number
3
Dosage Form
-
Strength
7.538GM/20ML (376.9MG/ML)
Approval Date
2026-08-10
Regulatory Status
RX
Drug Name
LIDOCAINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
1%
Approval Date
2026-03-19
Active Ingredient
LIDOCAINE HYDROCHLORIDE
Application Number
220071
Product Number
1
Dosage Form
-
Strength
1%
Approval Date
2026-03-19
Regulatory Status
RX
Drug Name
LIDOCAINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
2%
Approval Date
2026-03-19
Active Ingredient
LIDOCAINE HYDROCHLORIDE
Application Number
220071
Product Number
2
Dosage Form
-
Strength
2%
Approval Date
2026-03-19
Regulatory Status
RX
Drug Name
NITROGLYCERIN
Product Number
1
Dosage Form
-
Strength
0.3MG
Approval Date
2024-10-15
Active Ingredient
NITROGLYCERIN
Application Number
218583
Product Number
1
Dosage Form
-
Strength
0.3MG
Approval Date
2024-10-15
Regulatory Status
RX
Drug Name
NITROGLYCERIN
Product Number
2
Dosage Form
-
Strength
0.4MG
Approval Date
2024-10-15
Active Ingredient
NITROGLYCERIN
Application Number
218583
Product Number
2
Dosage Form
-
Strength
0.4MG
Approval Date
2024-10-15
Regulatory Status
RX
Drug Name
NITROGLYCERIN
Product Number
3
Dosage Form
-
Strength
0.6MG
Approval Date
2024-10-15
Active Ingredient
NITROGLYCERIN
Application Number
218583
Product Number
3
Dosage Form
-
Strength
0.6MG
Approval Date
2024-10-15
Regulatory Status
RX
Drug Name
PROCHLORPERAZINE EDISYLATE
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE/ML
Approval Date
2021-09-28
Active Ingredient
PROCHLORPERAZINE EDISYLATE
Application Number
213626
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE/ML
Approval Date
2021-09-28
Regulatory Status
RX
Drug Name
VARENICLINE TARTRATE
Product Number
1
Dosage Form
-
Strength
EQ 0.5MG BASE
Approval Date
2025-05-06
Active Ingredient
VARENICLINE TARTRATE
Application Number
212879
Product Number
1
Dosage Form
-
Strength
EQ 0.5MG BASE
Approval Date
2025-05-06
Regulatory Status
RX
Drug Name
VARENICLINE TARTRATE
Product Number
2
Dosage Form
-
Strength
EQ 1MG BASE
Approval Date
2025-05-06
Active Ingredient
VARENICLINE TARTRATE
Application Number
212879
Product Number
2
Dosage Form
-
Strength
EQ 1MG BASE
Approval Date
2025-05-06
Regulatory Status
RX
Drug Status Breakdown
14 total- RX
Official Source
FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.
Visit FDA Orange BookFDA Approved Drug Record Details Preview
Explore important FDA approved drug information available in the records above.
Drug Name
GADOBUTROL
Application Number
219287
Product Number
1
Active Ingredient
GADOBUTROL
Dosage Form
-
Strength
4.5354GM/7.5ML (604.72MG/ML)
FDA Approved Drug Data
Approved drug product information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized FDA drug records
Create a New Buying Request
Fields marked with * are mandatory.